• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/68

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

68 Cards in this Set

  • Front
  • Back
Early HSC development
A. initial site of HSC
B. common lymphoid progenitor gives
C. morphology of bone marrow
A. liver
B. T cell, B cell, NK
C. thin walled sinusoids lined by endothelial cells
- on discontinuous BM
- Red cell precursors surround macrophages (nurse cells) that give iron
A. Normal wya to estimate marrow activity
B. hypoplastic state ratio
C. in tumors, ratio
A. fat cell to hematopoietic elements = 1:1
B. fat cells increase
C. fat cells disappear
Disorders of White Cells
A. Proliferative disorders: 2 types
B. leukopenia: most common type
A. reactive; neoplastic
B. neutropenia
Leukopenia: neutropenia
A. def: neutroopenia
B.. def: agranulocytosis
C. sx of neutropenia
D, sx of agranulocytosis
E. morphology
A. red in # of neutrophils
B. clinically signficant reduction in neutrophils
C. malaise, chills, weakness, fever
D. infection = agranulocytic angina (any affecting oropharynx)
- deep fungal infxn (Candida and aspergillus)
E. hypercellular marrow
Neutropenia
A. pathogenesis (2)
A. inadq granulopoiesis: suppression of HSC
- suppression of committed granulocytic precursors
- ineffective hematopoiesis
- congenital conditions (Kostmann syn)
B. Accelerated removal
- immunologically mediated
- splenomegaly
- incr peripheral utilization
Reactive (Inflammatory) Proliferation
A. name two
- leukocytosis
- lymphadenitis: acute & chronic nonspecific
Leukocytosis pathogenesis
A. incr production in marrow
B. incr release from marrow stores
C. decr margination
D. decr extravasation into tissues
A. chronic infection
- paraneoplastic (Hodgkin)
- myeloproliferative (chronic myeloid leukemia)
B. endotoxemia, infxn, hypoxia
C. exercise, catecholamines
D. glucocoritcoids
Leukocytosis: types
A. neutorphilic
B. eosinophilic
C. Bsophilic
D. monocytosis
E. lymphocytosis
A. bacterial, pyogenic, tissue necrosis (MI)
B. allergic disorders (asthma); skin (pemphigus, dermatitis herpetiformis), malignancies (Hodgkin, non-Hodgkin)
C. myeloprolifeative (myeloid leukemia)
D. chronic infxn, SLE, mlcerative colitis
E. viral infxn, Bordetalla pertusis
Reactive changes in neutrophils
A. toxic granulations
B. Dohle bodies
C. cytoplasmic vacuoles
A. coarser, darker than normal primary granules
B. patches of dilated ER
Acute nonspeicifc lymphadenitis
A. morphology
- primary follicles enlarge = germinal centers where B cells develop
- for pyogenic infxn: follicles necrosis
Chronic nonspecific lymphadenitis
A. morphology of Follicular hyperplasia
B. "" paracortical hyperplasia
C. "" sinus histiocytosis (reticular hyperplasia)
A. germinal centers (secondary follicles) = light zone of centrocytes
- surrounded by resting naive B cell (centroblasts) = mantle zone
B. stimuli trigger T cell mediated repsonses = T cellzone efface B cell folicles
C. incr in # & size of cells that line lymphatic sinusoids = draining cancers (breast carcinoma)
Neoplastic WBC Proliferations
A. lymphoid neoplasms
B. myeloid neoplasms
C. histiocytoses
A. B-cell, T-cell, NK cell origin
B. acute myeloid leukemia (immature progenitor accum in bone marrow)
- myelodysplastic syndromes: ineff hematopoiesis = cytopenias
- chronic myeloproliferative: incr prod terminally myeloid (granulocytes)
C. prolif lesions of macrophges and dendritic cells
Lymphoid Neoplasms
A. leukemia def
B. Lymphoma def
C. Lymphoma categories
D. Lymphoma features (2)
A. neoplasms with widesprad involve of bone marrow
B. arise from discrete tissue masses
C. Hodgkin lymphoma: spread in orderly fashion
- plasma cell neoplasms
D. most B cell origin
- antigen receptor gene rearrange before transformation
Neoplasms of immature B and T cells
A. B cell acute lymphoblastic leukemia/lymphoma
B. T cell acute lymphoblastic leukemia/lymphoma
A. in children -> pancytopenia
B. adolescent males --> thymic masses
Neoplasms of mature B cells
A. Burkitt lymphoma
B. Diffuse large B cell lymphoma
C. Follicular lymphoma
D. Hairy cell leukemia
E. Mantle cell lymphoma
F. multiple myeloma
G. Chronic lymphocytic leukemia
A. t(8;14) -> c-MYC --> young adults with extranodal mass
B. rapidly growing masses
C. t(14;;18) -> adults with generalized lymphadenopathy
D. memory cells --> males w/ pancytopenia & splenomegaly
E. t(11;14) -> males with disseminated disease
F. lytic bone lesions, hypercalcemia, renal failure
G. bone marrow, lymph node, spleen, liver disease
Neoplasms of mature T cells/NK cells
A Adult T cell leukemia/ lymphoma
B. Sezary syndrome
Large ranular lymphocytic leukemia
A. HTLV virus --> cutaneous lesions, hypercalcemia
B. helper T-? cutaneous patches, plaques, gen erythema
C. T and NK cells --> splenomegaly, neutropenia, anemia
Acute lymphoblastic Leukemia/Lymphoma (ALL)
A. B-ALL
B. T-ALL
C. vs AML
A. childhood (3 yo) leukemia = loss-of-fxn (PAX5)
B. adolescent thymic lymphomas = gain of fxn (NOTCH1)
C. lymphoblasts more condensed chromatin, smaller cytoplasm that lacks granules
ALL
A. sx
B. dx
A. sx related to decr marrow fxn: anemia fatigue, fever b/s neutropenia, bleeding due to thrombocytopenia
- sx of neoplastic infiltraion: bone pain, heptosplenomega
B. Ig for B/T antigens.
- lymphoblasts myeloperoxidase-neg adn acid-Schiff - pos cytoplasm (in contrast myeloblasts)
Chronic Lymphocytic Leukemia (CLL)
A. morphology
B. immunophenotype
A. small lymphocyte infiltrate mixed with proliferation centers = aggregates of activated lymphocytes
- smudge cells: lymphocytes disupted in making smears
B. pan-B cell markers
CLL
A. sx
- nonspecific: weight loss, anorexia, fatigue
- disrupt normal immune fxn
- transform to more aggressive tumors
- Richter syndrome: transform to diffuse large B cell lymphoma
Follicular Lymphoma
A. stat
B. morphology
C. moleuclar pathogenesis
A. most common form of indolent NHL
B. 2 cel types: centrocytes = small cleaved cells + centroblasts = larger cells w/ cytoplsm, nuclear chromatin
C. (14;18) translocation = overexpression of BCL2 = no apoptosis
Follicular lymphoma
A. sx
- painless, generalized lymphadenopathy
- histo transf to diffuse large B cell lymphoma
Diffuse large B cell lymphoma
A. stat
B. morphology
C. immunophenotype
D. moelcular pathogenesis
A. most common form of NHL
B. large cell size with large nuclei, open chromatin
- diffuse pattern of growth
C. mature Bcell marker: CD19, CD20
D. BCL6 dysrg = silence expression of P53
diffuse large b-cell lymphoma
A. subtypes
B. sx
A. immunodef - associated large Bcell lymphoma: B cells infected with EBV b/c T-cell immundef
- primary effusion lymphoma: malignant pleural/ascitic effusion = tumor cells infected with KSHV/HHV-8
B. rapidly enlarging mass at nodal or extranodal site
- aggresstive tumors (tx w/ anti-CD20 Ig)
Burkitt Lymphoma
A. type(s)
B. morphology
C. molecular pathogenesis
A. African (endemic) vs sporadic (nonendemic)
B. intermediate sized
- high mitotic index with numerous apoptotic cells
- starry sky pattern b/c of lots of macrophages (pale)
C. translocations of c-MYC gene on chromo 8 [t(8;14)]
- endemic: infxn with EBV
Burkitt lymphoma
A. sx
B. prognosis
- manifest at extranodal sites
- endemic: mandible, involving abdominal viscera (kidney, ovaries, adrenals)
- sporadic: ileocecum, peritoneum
B. aggressive but resonds well
Plasma Cell neoplasms = dyscrasias
A. def M component
B. heavy and light chains production
C. name types
A. M component = monoclonal Ig in blood
B. usu balanced but in neoplastic plasma cells = excess light or heavy chaings along with complete Ig
C. Multiple Myeloma
- plasmacytoma, smoldering myeloma
- MGUS, lymphoplasmacytic lymphoma
Multiple Myeloma
A. molecular pathogenesis
B. sx
A. somatichypermutation = post-germinal center B cell home to bone marrow & differentiated into plasma cell
- survival of myeloma cell dep on IL-6
- neoplastic plasma cells mediate bone destruction
B. bone resorption --> fractures, chronic pain, hypercalcemia
- recurrent bacterial infxn b/c sup of humoral immunity
- renal insufficiency b/c Bence Jones proteinuria
Multiple Myeloma
B. dx findings
- XRAY punched out defects
- pathologic fractures (vertebral column)
- diffuse demineralization (osteopenia), not focal defect
- plasma cells w/ multiple nuclei, prominent nucleoli, cyoplasmic droplets containing Ig
- globular inclusions = Russell bodies (ctoplasmic ) or Dutcher bodies (if nuclear)
- rouleaux formation
- myeloma kidney (from Bence Jones protein = light chain)
Multiple myeloma
A. tx
- inhibitors of proeasome
- biphosphonates: inhibit bone resorption
- prognosis poor
Solitary Myeloma (plasmacytoma)
A. defintion
B. progression
A. solitary lesion of bone or soft tissue
B. takes 15-20 yrs to progress to MM
Smoldering Myeloma
A. definition
A. asymp but M protein level is ? 3 gm/dL
- takes 15 years to progress to MM
Monoclonal Gammopathy of Uncertain Significance (MGUS)
A. stat
B. progression
A. most common dyscrasia. mostly in elderly
B. 1% develop MM per year
Lymphoplasmacytic lymphoma
A. vs CLL
B. vs MM
C. morphology
D. tx
A. B cell neoplasm = cells undergo dif to plasma cells
B. heavy & light chain syn balanced
- no bone destruction and complication from secretion of free light chain is rare
C. periodic acid-Schiff pos inclusions continaing Ig = Russell bodies if cytoplasmic or Dutcher bodies
D. plasmapheresis
Lymphoplasmacytic lymphoma
A. clinical sx
- nonspecific: weakness, fatigue, wt loss
- lymphadenopathy, heptosplenomegaly
- Waldenstrom macroglobulinemia: hyperviscosity from excess monoclonal IgM = viusla impairment, neurologic problems, bleeding, cryoglobulinemia (precipitation of macroglobulins at low temp = Raynaud phenomena)
Mantle Cell Lymphoma
A. morphology
B. immunophenotype/pathogenesis
C. vs CLL and follicular lymphoma
D. prognosis
A. small lymphoid cells w/ irreg nuclear outlines, cleaved membrane, condensed chromatin, scant cytoplasm
B. high cyclin D1 cased by (11;14) translocation
C. large cells (centroblasts) and proliferation centers absent.
D. no curable with chemo -> succumb to organ dysfxn
Marginal Zone lymphomas
A. location
B. pathogenesis point
A. mucosa-assocaited lymphoid tumors (maltomas)
B. arise from chornic inflam areas and can regress if agent removed
Hairy Cell leukemia
A. epidemio
B. morphology
C. sx
A. middle-aged white male
B. fine hairlike projections from cells that enmeshe din ECM = dry tap (not aspirated)
- splenic red pulp infilted --> no white pulp
C. splenomegaly, pancytopenia
Anaplastic large-cell lymphoma (ALK positive)
A. molecular pathogenesis
B. morphology
C. prognosis
A. rearrangement of ALK gene on chromo 2p23
--> activate tyrosine kinases
B. horsehowe-liek nuclei and abundate cytoplasm
C. good prognosis
Adult T-cell leukemia/lymphoma
A. hallmark
B. cell morphology
A. infected w/ HTLV-1 (human Tcell leukemia retrovirus)
B. multilobated nuclei
Mycosis Fungoides/Sezary sndrome
A. def
B. phases of mycosis fungoides
C. Sezary syndrome sx
A. tumor of CD4 helper T cells with CLA, CCR4, CCR10 markers tha thome to skin
B. inflam premycotic phase, plaque phase, tumor phase
C. generalized exfoliative erythroderma that rearely proceed to tumefaction
- Sezary cells w/ cerebriform nuclei
Large Granular Lymphocytic leukemia
A. morphology of tumor cells
B. hallmarks sx
A. large lymphocytes w/ abundant blue cytoplasm + few coarse azurophilic granules
B. neutropenia and anemia but paucity of marrow infiltration
Extranodal NK/T cell lymphoma
A. morphology
B. sx
A. tumor cell (NK markers) surround and invade small vessels = ischemic necrosis. cell is invaded with EBV
B. destructive nasopharygeal mass
Hodgkin lymphoma vs NHL
A. localized to single axial group of nodes; mulitple peripheral nodes
B. contiguity spread; noncontinguous
C. mesenteri nodes/Waldeyer ring not involved; involved
D. extra-nodal rare; common
Hodgkin lymphoma
A. hallmark morphology
B. Reed-sternberg cell variants
C. diff from large-cll NHL or mononucleuosis
A. Reed-Sternberg cells surrounded lymphocytes, macrophages, granulocytes
B. mononuclear variants: single nucleus w/ large inclusion-like nucleolus
- Lacunar cell: abundant cytoplasm disrupted durign sections = nucleus sitting in empty hole
C. HL = reed-sternberg in background of non-neoplastic inflam cells
Hodgkin lymphoma
A. nodular sclerosis
B. lymphocyte predominance
A. lacunar variant + collagen in bands that divide lymph nodes into circumscribed nodules
- cells postive for PAX5 (B-cell)
B. L&H variants (lymphocytic and histiocytic) express B cell markers typical of germinal -center B cells
Hodgkin lymphoma
A. MixedCellularity type
B. Lymphocyte-rich type
C. lymphocyte depletion
A. RS cells + mononulclear variants infected w/ EBV
B. reactive lymphocytes infiltrates.
C. paucity of lymphocytes but abundant RS cells
- immunophenotyping essential to distinguish from large-cell NHL
Hodgkin lymphoma
A. molecular pathogenesis
B. spread of HL
C. sx
A. RS cell undergone VDJ recombo and somati chypermutation but fail to express B cell specific genes
- activation of NF-kB by EBV rescues crippled germinal center B cells form apoptosis
B. nodal -> splenic dz --? hepatic --> marrow
C. painless lymphadenopathy, fever, night sweats
Myeloid neoplasms
A. types
- acute myeloid leukemia: accum of immatur emyeloid forms (blasts) = suppresses hematopoiesis
- myelodysplastic syn: ineffective hematopoiessi --> cytopenias
- myeloproliferativce disorder: incr prod of >1 blood cell
Acute myeloid leukemia
A. def
B. sx
C. morphology
A. accumulation of immature myeloid blasts in marrow
B. anemia, thrombocytopenia, neutropenia
B. >20% myeloid blasts in bone marrow
- myeloblasts: delicate nuclear chromatin, > 2 nucleoli, > cytoplasm than lymphoblasts
- Auer rods: needle-like azurophilic granules in t(15;17)
- mono-blasts: foldednuclei lack Auer rods
Acute myeloid leukemia
A. molecular apthogenesis
B. t(15;17) tx
A. mutated tyrosine kinases collaborate w/ transcription factor aberratiosn = AML
B. t(15;17) creats fusion gene that encodes part of retinoic aicd recptor (RARalpha)
- ATRA (all-trans retinoic acid) binds to PML-RARalpha fusion protein and antagonizes inhibitory effect on transcritpion of target genes
Myelodysplastic syndrome
A. hallmark
B. molecular pathogenesis
A. bone marrow replaced by clonal progeny of neoplastic multipotenet stem cell
B. progenitors undergo apoptosis at incr rate but ineffective hematopoiesis
Myelodysplastic syndrome
A. morphology
- disordered (dysplastic) differentiation
- ringed sideroblasts: erythr w/ iron-laden mitochondria
- megaloblastoid maturation (like VitB12 def)
- nuclear budding abnl
- pseudo-pelger-Huet cells: neutrophils w/ 2 nuclear lobes
- pawn ball megakaryocytes: multiple nuclei not single
- myeloid balsts <20% of overall marrow cellularity
Myeloproliferativ edisorders
A. molecular pathogenesis
B. name types
A. activated tyrosine kinase = incr prod of mature blood elements
B. chronic myeloid leukemia (BCR-ABL)
- polycythemia vera (JAK2)
- essential thrombocythemia (JAK2)
- primary myelofibrosis (JAK2)
Chronic Myeloid leukemia
A. molecular pathogenesis
B. morphology
A. BCR-ABL fusion gene self activates
B. hypercellular in granulocytes, megakaryocytes
- macrophages = sea-blue histiocytes b/c cytoplasm
- leukocytosis
chronic Myeloid leukemia
A. sx
B. tx
A. dragging sesation in abdomen = splenomegal b/c extramedullary hematopoisesis
- ULQ pain = splenic infarct
- anemia, thrombocytopenia
B. imatinib decr # of BCR-ABL cells but not kill CML stem cell
Polycythemia Vera
A. hallmark
B. morphology
C. sx
A. panmyelosis (incr prod of everything) but incr RBC most trouble
B. extensive marrow fibrosis
- incr extramedullary hematopoiesis
- oranomegaly
C. plethoric & cyanotic due to stagnation of blood
- headache, HTN, GI sx
- major bleeding and thrombotic episodes
Essential thrombocytosis
A. vs PCV vs primary myelofibrosis
B. lab dx
C. sx
A. vs PCV (absence of polycythemia)
- vs primary myelofibrosis (absence of fibrosis)
B. peripheral smear: abnl large platelets
C. thrombosis, hemorrhage
- erthromelalgia (thrombing/burning of hands by occlusion of small arterioles)
- DVT, portal vein thrombosis, MI
Primary myelofibrosis
A. hallmark
B. molecular pathogenesis
C. sx
A. obliterativ emarrow fibrosis --> cytopenia + neoplastic extramedulalry hematopoiesis
B. neoplastic megakaryocytes release fibrogenic factors
C. > 60 yo, hyperuricemia, secondary gout
- anemia, splenomegaly (fullness in ULQ)
Primary myelofibrosis
A. morphology
- megakaryocytes large, dysplastic, abnl clustered
- fibrotic obliteration --> exramed hematopoiesis
- leukoerythroblastosis: premature release of nucleated erythroid
- teardrop-shaped red cells (dacryocytes)
Langerhas cell histiocytosis
A. hallmark
B. multifocal multisystem LCH
C. eosinophilic granuloma
D hand-schuller-christian triad
A. birbeck granules in cytoplasm: pentalminal tubule with dilated terminal end = teniis racket appearance
B. cutaneous lesions rembling seborrheic eruption
C. prolif LC mixed with eosinophils, lympho, plasma, neutrophils
D. triad of calvarial bone defect, DI, exophthalmos
Spleen
A. anatomy
B. two routs to splenic veins
A. red pulp traversed by thin-walled vascular sinusoids separted by cords of Billroth
- white pulp follicules = arter with collar of T lymphocytes = periarteriolar lymphati cshealth
- sheat expands to form lymphoid nodules of B lymph
B. RBC into cords, squeezing throgh gpas to reach = open circuation
- blood directly into splenic viens
Spleen
A. 4 fxns
B. infectious caveat
A. phagocytosis of blood cells
- Ig production
- hematopoiesis
- sequestion of platelet (htrombocytopenia) or WBC if splenomegaly
B. susceptibility to sepsis by encap bacteria (H. flu, penmunoccus, meningocccus)
Splenomegaly
a. hypersplenism def
B. morphology
A. anemia, leukopenia, thrombocytopenia b/c incr sequestration and phagocytosis
B.. congestion of red pulp
Congestiv esplenomegaly
A. causes
B. morphology
A. right side heart failure
- cirrhosis
- schistosomiasis
- spontaneous portal vein thrombosis
- pylephlebitis
B. thickened fibrous capsule with firbotic red pulp
A. types of congenital anomalies
B. spleen rupture consequences
A. hypoplasia, accessory spleens
B. caused by blunt trauma --> rapidly enlarging capsule that is thin = easy to rupture --> intraperitoneal hemorrhage
Thymus
A. anatomy
B. Thymic hyperplasia
A. medullary epithelia cells create Hassall corpuscles (whorls)
B. appearance of B cell germinal centers (seen in myasthenia gravis)
Thymomas
A. morphology
B. noninvasive tymomas
C. invasive thymoma
D. thymic carcinoma
E. sx
A. lobulated, gray-white masses
B. medullary type epithelial cells = elongated or spindle shaped
C. corticla epithelial cell = abundant cytoplasm + vesicular nuclei. penetrate through capsule to surrounding structures
D. squamous cell carcinomas
E. impingement on mediastinal structures